RUMAN RAHMAN RUMAN.RAHMAN@NOTTINGHAM.AC.UK
Associate Professor
Histone deacetylase inhibition as an anticancer telomerase-targeting strategy
Rahman, Ruman; Grundy, Richard
Authors
RICHARD GRUNDY richard.grundy@nottingham.ac.uk
Professor of Paediatric Neuro-Oncology
Contributors
RUMAN RAHMAN RUMAN.RAHMAN@NOTTINGHAM.AC.UK
Project Leader
Abstract
Aberrant epigenetic regulation of gene expression contributes to tumor initiation and progression. Studies from a plethora of hematologic and solid tumors support the use of histone deacetylase inhibitors (HDACi) as potent anticancer agents. The mechanism(s) of HDACi-induced cancer growth inhibition and cell death are complex and incompletely elucidated. Here, we discuss erroneous epigenetic regulation of hTERT transcription in cancer cells and propose that alleviation of an improper acetylation–deacetylation balance at the hTERT promoter, is one mode by which HDACi induces anticancer effects. We conclude with some pertinent questions and future perspectives arising from the recent impetus in HDACi preclinical and early clinical studies, with particular attention to the cancer stem cell therapeutic paradigm and its relevance to tumor resistance.
Citation
Rahman, R., & Grundy, R. (2011). Histone deacetylase inhibition as an anticancer telomerase-targeting strategy. International Journal of Cancer, 129(12), 2765-2774. doi:10.1002/ijc.26241
Journal Article Type | Article |
---|---|
Acceptance Date | May 30, 2011 |
Online Publication Date | Aug 8, 2011 |
Publication Date | Dec 15, 2011 |
Deposit Date | Dec 5, 2018 |
Journal | International Journal of Cancer |
Print ISSN | 0020-7136 |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
Volume | 129 |
Issue | 12 |
Pages | 2765-2774 |
DOI | https://doi.org/10.1002/ijc.26241 |
Keywords | Cancer Research; Oncology |
Public URL | https://nottingham-repository.worktribe.com/output/1370558 |
Publisher URL | https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.26241 |
You might also like
Electric field responsive nanotransducers for glioblastoma
(2022)
Journal Article
Metabolic modeling-based drug repurposing in Glioblastoma
(2022)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: digital-library-support@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search